LILRA3 Monoclonal Antibody (6F12D7), Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | FERMA548710-Each-of-1 | In Stock | ₹ 43,565.50 |
FERMA548710 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 43,565.50
GST (18%): ₹ 7,841.79
Total Price: ₹ 51,407.29
Antigen
LILRA3
Classification
Monoclonal
Concentration
1 mg/mL
Formulation
PBS with 0.05% sodium azide
Gene Accession No.
Q8N6C8
Gene Symbols
LILRA3
Immunogen
Purified recombinant fragment of human LILRA3 (AA: 24-168) expressed in E. Coli.
Quantity
100 μg
Primary or Secondary
Primary
Target Species
Human
Form
Liquid
Applications
ELISA, Flow Cytometry, Immunocytochemistry, Western Blot
Clone
6F12D7
Conjugate
Unconjugated
Gene
LILRA3
Gene Alias
CD85 antigen-like family member E; CD85e; HM31; HM43; ILT6; ILT-6; Immunoglobulin-like transcript 6; leucocyte Ig-like receptor A3; leukocyte immunoglobulin like receptor A3; leukocyte immunoglobulin-like receptor 4; leukocyte immunoglobulin-like receptor A3; leukocyte immunoglobulin-like receptor subfamily A member 3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3; LILRA3; LIR4; LIR-4; Monocyte inhibitory receptor HM43/HM31
Host Species
Mouse
Purification Method
Protein G
Regulatory Status
RUO
Gene ID (Entrez)
11026
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Isotype
IgG1
Related Products
Description
- Leukocyte Ig-like receptors (LIRs) are a family of immunoreceptors expressed predominantly on monocytes and B cells and at lower levels on dendritic cells and natural killer (NK) cells
- All LIRs in subfamily B have an inhibitory function (see, e.g., LILRB1, MIM 604811)
- LIRs in subfamily A, with short cytoplasmic domains lacking an immunoreceptor tyrosine-based inhibitory motif (ITIM) and with transmembrane regions containing a charged arginine residue, may initiate stimulatory cascades (see LILRA1, MIM 604810)
- One member of subfamily A (LILRA3) lacks a transmembrane region and is presumed to be a soluble receptor (Borges et al., 1997 [PubMed 9548455]).